Brochure
19 Oct 2022
SOFTGELS

PDF 3.0 MB
Content provided by our supplier
Aenova Holding GmbH

-
DE
-
2015On CPHI since
-
1000 - 4999Employees
Company types
Other Content from Aenova Holding GmbH (8)
-
News Aenova publishes white paper on the "Safe and efficient handling of high potent drug products"
High-potent drug products for oncology or hormone therapy will play an important role in innovative drug therapy in the future. The development and production of drugs with high-potent active ingredients is highly complex and often must be implemented with acceleration. Handling of high potent solid dosage forms therefore is a key need of current pharmaceutical development and manufacturing. To ensure safe and efficient handling of high potency products, mastering a holistic production approach is essential. This drives a fast time-to-market for your new high potent product.
-
Brochure AENOVA CAPABILITIES
As a leading global contract manufacturer and development service providerwith 15 production sites in Europe and the USA, we offer extensive capabilitiesfor Steriles, Semi-Solids, Solids and Packaging. -
News Aenova expands portfolio with innovative technologies
The development of new drug products for a wide range of therapeutic areas is a rapidly growing market. Therefore, a smart innovation strategy is essential for contract developers and manufacturers. Aenova is expanding its development and production portfolio, particularly in the area of bioavailability of active pharmaceutical ingredients.
-
Brochure AENOVA Corporate Brochure
Excellence beyond Manufacturing -
Brochure Innovative Technology Solutions at Aenova
ENHANCING NOVEL MEDICINES -
Brochure ANIMAL HEALTH Market
Leading Capabilities for a Growth Market -
Whitepaper Cannabinoids. Therapeutic effects and the advantages of soft capsules as appropriate dosage form
Cannabinoids can provide great benefits for the treatment of cancer and central nervous system diseases. Softgel capsules are the preferred delivery form for cannabinoid products for many reasons. Learn more with the new Aenova white paper! -
Whitepaper Safe and efficient handling of high potent drug products. A holistic concept
High potent drug products for e.g. oncology or hormone therapy will play an important role in innovative drug therapy in the future. The development and production of drugs with high potent active ingredients is highly complex and often must be implemented with acceleration. Handling of high potent solid dosage forms therefore is a key need of current pharmaceutical development and manufacturing. To ensure safe and efficient handling of high potency products, mastering a holistic production approach is essential. This drives a fast time-to-market for your new high potent product. Learn more in the latest whitepaper from Aenova.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance